GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Cyclically Adjusted Price-to-FCF

HLB Panagene Co (XKRX:046210) Cyclically Adjusted Price-to-FCF : (As of Sep. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


HLB Panagene Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for HLB Panagene Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co Cyclically Adjusted Price-to-FCF Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HLB Panagene Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HLB Panagene Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, HLB Panagene Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's Cyclically Adjusted Price-to-FCF falls into.



HLB Panagene Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

HLB Panagene Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, HLB Panagene Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-2.977/*
=

Current CPI (Jun. 2024) = .

HLB Panagene Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.000 99.608 0.000
201412 -95.532 99.098 0.000
201503 -16.598 99.720 0.000
201506 -42.523 100.050 0.000
201509 14.988 100.110 0.000
201512 -11.455 100.220 0.000
201603 -42.270 100.560 0.000
201606 -49.862 100.790 0.000
201609 -8.711 101.460 0.000
201612 -37.761 101.560 0.000
201703 136.325 102.850 0.000
201706 -59.369 102.610 0.000
201709 -74.996 103.490 0.000
201712 -214.946 102.990 0.000
201803 -14.716 104.100 0.000
201806 15.859 104.130 0.000
201809 -0.958 105.650 0.000
201812 4.808 104.350 0.000
201903 -30.398 104.490 0.000
201906 3.900 104.880 0.000
201909 9.761 105.200 0.000
201912 20.286 105.120 0.000
202003 14.092 105.540 0.000
202006 39.539 104.870 0.000
202009 2.021 106.200 0.000
202012 63.757 105.765 0.000
202103 51.331 107.357 0.000
202106 51.705 107.579 0.000
202109 42.959 108.759 0.000
202112 26.736 109.676 0.000
202203 1.387 111.806 0.000
202206 30.252 114.083 0.000
202209 24.575 114.831 0.000
202212 38.237 115.200 0.000
202303 33.516 116.550 0.000
202306 -30.003 117.140 0.000
202309 -29.315 119.111 0.000
202312 14.657 118.848 0.000
202403 -1.383 118.848 0.000
202406 -2.977 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HLB Panagene Co  (XKRX:046210) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


HLB Panagene Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co Headlines

No Headlines